What is the current stock price of Franklin Genomic Advancements ETF (HELX)?

As of the latest market data, Franklin Genomic Advancements ETF (HELX) is trading at $33.97. The stock has seen a loss of -1.44% today.

Does Franklin Genomic Advancements ETF (HELX) pay a dividend?

Based on current data, Franklin Genomic Advancements ETF does not have a confirmed active dividend policy.

What is the market cap of Franklin Genomic Advancements ETF?

The current market capitalization of Franklin Genomic Advancements ETF (HELX) is approximately unavailable.

HELX

Franklin Genomic Advancements ETF·Financial Services

33.97

1.440%(−0.50)

Close Price

38.47

13.247%(+4.50)

Pre-Market

Last Updated: — ET

52W L: $24.9452W H: $38.17

Company Profile

The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.

Sector

Financial Services

Industry

Asset Management

IPO Date

2020-02-27

Beta

1.20